For the first time, the export of a shipment of AstraZeneca corona vaccines from the EU has been stopped.
A batch of 250,000 vaccines may not be exported from Italy and the European Commission to Australia, Brussels sources confirm after a report by the Financial Times.
AstraZeneca has been supplying the European Union with less than agreed for some time. Deliveries next spring are also likely to be disappointing.
If a vaccine manufacturer does not meet its obligations, EU countries and the European Commission can block exports.
A manufacturer must inform the EU country where it operates of a planned export. That country, in this case, Italy, submits its decision to the committee, which has the final say.